Terms: = Head and neck cancer AND TOP2A, TOP2, TP2A AND Diagnosis
4 results:
1. Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis.
Yang T; Chen Y; Xu J; Li J; Liu H; Liu N
BMC Complement Med Ther; 2022 Jan; 22(1):21. PubMed ID: 35078445
[TBL] [Abstract] [Full Text] [Related]
2. Molecular biomarker identification for esophageal adenocarcinoma using endoscopic brushing and magnified endoscopy.
Goda K; Murao T; Handa Y; Katsumata R; Fukushima S; Nakato R; Osawa M; Ishii M; Fujita M; Handa O; Matsumoto H; Fujita Y; Nishio K; Wallace TM; Gomez-Esquivel R; Berzosa M; Wolfsen HC; Wallace MB; Umegaki E; Shiotani A
Esophagus; 2021 Apr; 18(2):306-314. PubMed ID: 32728973
[TBL] [Abstract] [Full Text] [Related]
3. top2a overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.
Lan J; Huang HY; Lee SW; Chen TJ; Tai HC; Hsu HP; Chang KY; Li CF
Tumour Biol; 2014 Jan; 35(1):179-87. PubMed ID: 23897556
[TBL] [Abstract] [Full Text] [Related]
4. A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.
Denning KM; Smyth PC; Cahill SF; Finn SP; Conlon E; Li J; Flavin RJ; Aherne ST; Guenther SM; Ferlinz A; O'Leary JJ; Sheils OM
Mod Pathol; 2007 Oct; 20(10):1095-102. PubMed ID: 17660800
[TBL] [Abstract] [Full Text] [Related]
